罗氏全球扩展英伟达AI工厂,加速药物研发、诊断方案与制造突破

美股速递
5 hours ago

罗氏控股有限公司正加速在全球范围内扩展与英伟达合作的人工智能工厂,旨在显著提升药物发现效率、优化诊断解决方案,并推动制造领域的突破性进展。这一战略举措将利用英伟达先进的AI计算能力,整合罗氏在生物医药领域的专业优势,共同应对医疗健康行业的核心挑战。

通过部署英伟达的AI基础设施,罗氏计划强化其研发管线,缩短新药上市周期,同时提高诊断工具的精准度和可及性。此外,双方合作还将探索智能制造技术在医药生产过程中的应用,以提升运营效率和产品质量。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10